Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

11.95
BATS BZX Real-Time Price
As of 12:37pm ET
 -0.20 / -1.65%
Today’s Change
11.34
Today|||52-Week Range
27.02
-33.68%
Year-to-Date
No recent news for Depomed Inc.

Today’s Trading

Previous close12.15
Today’s open12.10
Day’s range11.90 - 12.12
Volume23,203
Average volume (3 months)1,588,817
Market cap$754.5M
Dividend yield--
Data as of 12:37pm ET, 04/28/2017

Growth & Valuation

Earnings growth (last year)-15.08%
Earnings growth (this year)+41.48%
Earnings growth (next 5 years)+19.00%
Revenue growth (last year)+33.02%
P/E ratioNM
Price/Sales2.42
Price/Book3.00

Competitors

 Today’s
change
Today’s
% change
ACRSAclaris Therapeutics...-0.30-1.04%
MGNXMacroGenics Inc-0.17-0.78%
HSKAHeska Corp-1.02-0.97%
CYTKCytokinetics Inc-0.60-3.53%
Data as of 12:37pm ET, 04/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)$0.11
Annual revenue (last year)$455.9M
Annual profit (last year)-$88.7M
Net profit margin-19.46%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Arthur Joseph Higgins
Chief Financial Officer &
Senior Vice President
August J. Moretti
Corporate headquarters
Newark, California

Forecasts